Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 6 to 80

Comparing emergency spacers to traditional spacers for delivering asthma medication

Official title: Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs

Run by Beni-Suef University · NCT06816342 · Data updated 2026-11-12

This study is testing whether using emergency spacers instead of traditional spacers helps deliver asthma medication more effectively for both kids and adults.

More Aerosol Generating Procedure trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages6 Years to 80 Years
SexAll
Enrollment120 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Egypt)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedFebruary 10, 2025
Study endsFebruary 10, 2025
Registry record updatedFebruary 10, 2025
Trial IDNCT06816342 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are mild to moderate asthmatic patients aged 6 to 80 years.

Probably not a fit

Patients with severe asthma, those in intensive care, or individuals with certain health conditions such as ischemic heart disease or hypersensitivity to salbutamol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the performance, feasibility, and safety of emergency spacers versus traditional spacers for delivering aerosolized drugs using pressurized metered-dose inhalers (pMDI) in both young children and adult asthmatic patients. The study aims to measure the total emitted dose from pMDI, assess pharmacokinetic parameters, and evaluate lung and systemic bioavailability of the aerosol delivered by different spacers. Additionally, it will analyze lung function post-delivery and monitor safety outcomes. By comparing the effectiveness of various spacers, the trial seeks to improve asthma management through better medication delivery.

Why it matters

Potential benefit: If successful, this study could enhance the effectiveness of asthma treatment by optimizing aerosol drug delivery methods.

How similar studies have gone: Other studies have shown promising results in improving aerosol delivery methods, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Mild and moderate asthmatic patients aged from 6 - 80 year old.

Exclusion Criteria:

* Severe asthmatics or patients admitted to an intensive care unit
* ischemic heart disease
* recent abdominal surgery
* inability to perform properly the pulmonary function tests
* hepatic or renal impairment
* hypersensitivity to salbutamol.

Where it's running

  • Beni-Suef university hospital
    Banī Suwayf, Egypt, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.